
Understanding food allergies: symptoms, common triggers and how to manage them
11th June 2026
TITLE: Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial
27th October 2026



